Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-07

FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Epic Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for Bupropion Hydrochloride SR from Epic Pharma, LLC (ANDA216766). This action reflects an approved modification to the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride SR (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE SR (BUPROPION HYDROCHLORIDE)